Therefore, in the case we presented, healthy CCM2 IVS10-1G>A mutation carriers might not have developed CCM phenotype due to a greater compensatory activity of CCM2L. This hypothesis is being evaluated. The gene discussed is CCM2; the disease is cerebral cavernous malformation.